Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Director/PDMR Shareholding

12 Mar 2024 16:39

The Biotech Growth Trust Plc - Director/PDMR Shareholding

The Biotech Growth Trust Plc - Director/PDMR Shareholding

PR Newswire

LONDON, United Kingdom, March 12

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Hamish Baillie

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

The Biotech Growth Trust PLC

b)

 

LEI

 

 

549300Z41EP32MI2DN29

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 25p shares

 

 

GB0000385517

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

974.6843 pence per share

 

3,000 shares

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

3,000 ordinary 25p shares

 

 

974.6843 pence per share

 

e)

 

Date of the transaction

 

 

12 March 2024

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

Name of authorised official of issuer responsible for making notification:

 

Katherine Manson, for and on behalf of Frostrow Capital LLP

Company Secretary to THE BIOTECH GROWTH TRUST PLC



Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.